Relay Therapeutics Inc (RLAY)
$18.35 -5.75% Close Oct 30, 2026 Live
Relay Therapeutics stock today
Relay Therapeutics closed at $18.35 on October 30, 2026, down 5.75% on the day. Over the past year it returned +150.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.52 billion.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | RLAY | S&P 500 (SPY) |
|---|---|---|
| 1 month | +1.7% | -0.9% |
| 3 months | -5.7% | +2.1% |
| Year to date | +116.9% | +11.7% |
| 1 year | +150.0% | +12.4% |
| 3 years | +194.5% | +88.5% |
| 5 years | -44.8% | +76.0% |
Key statistics
- Market value
- $3.52B
- Price / sales
- 339.7
- 52-week range
- $6.05 to $20.75
- Next report
- Nov 4, 2026
About Relay Therapeutics
Develops small molecule drugs targeting protein-protein interactions for cancer and other diseases.
Sector: Health Care
More on Relay Therapeutics
- Financials: revenue, earnings and segmentsRevenue +53% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $551.88 today
No forecast, no recommendation. This page describes Relay Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.